Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: American Society of Clinical Oncology (ASCO) Guideline Recommendations, Slide Set

QualityTool

Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: American Society of Clinical Oncology (ASCO) Guideline Recommendations, Slide Set

Description

This slideshow summarizes the guideline recommendations developed by the American Society of Clinical Oncology on the use of sentinel lymph node biopsy (SNB) in early-stage breast cancer.

This slideshow addresses the following topics:

  • Guideline methodology
  • Background
  • Guideline questions
    • Can full axillary lymph node dissection be avoided in patients with negative findings on SNB?
    • Is full axillary lymph node dissection necessary for all patients with positive findings on SNB?
    • What is the role of SNB in special circumstances in clinical practice?
    • What factors affect the success of SNB?
    • What are the potential benefits and harms of SNB?
  • Special circumstances
  • Considerations
  • Summary
  • Conclusions

Developer:

American Society of Clinical Oncology

Funding Sources:

American Society of Clinical Oncology

History

Release Date: 2005
Original Summary: April 2006
Last Updated: 04/10/13

QualityTool Classification

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.